NEW
Font size
WorksheetsTatalaksana Retinopati Diabetik
Total questions: 10
Worksheet time: 5mins
1. Below are the characteristic of severe DME
retinal thickening
hard exudate
involving the centre of macula
all true
Characteristics of focal CSME, except :
Microaneurism
FFA reveals focal leakage with adequate macular perfussion
Macular edema
Diffuse retinal edema and thickening throughout posterior pole
When is the right time for early detection of diabetic retinopathy on type 2 DM?
2 years after diagnosed
3 months after diagnosed
At time of diagnosis
5 years after diagnosed
Which one is true about follow up severe NPDR with center-involved DME
Every month
2-4 months
3-4 months
6 months
Below is mechanism of Bevacizumab as Anti-VEGF agent
Competitively binds to the VEGF-A165 isoform at the heparin binding site
Binds to the receptor binding site for all isoforms of VEGF-A
Neutralizes all forms of VEGF-A
Soluble docoy receptor with high affinity for binding to VEGF molecules VEGF-A and PIGF
Indications of vitrectomy for diabetic retinopathy, except
Nonclearing vitreous hemorrhage
Tractional retinal detachment not threatening the macula
Combined rhegmatogenous and tractional retinal detachment
Dense pre-macular subhyaloid hemorrhage
Indication of steroid use on DME
-phakic
-recurrent
-vitrectomized eye
-all true
The modality options for managing DME with good vision in protocol V are:
a. focal lasers
b. aflibercept
c. observation
d. not all three
Indication of steroid use on DME
-phakic
-recurrent
-vitrectomized eye
-all true
Diagnostic modalities of diabetic retinopathy
a. retinometer
b. fundoscopy
c. OCT
d. FFA
